{"id":15666,"date":"2024-08-20T18:10:20","date_gmt":"2024-08-20T22:10:20","guid":{"rendered":"https:\/\/tribu.la\/?p=15666"},"modified":"2024-08-20T18:10:23","modified_gmt":"2024-08-20T22:10:23","slug":"botanical-solution-inc-secured-7-6-million-in-series-a-extension","status":"publish","type":"post","link":"https:\/\/tribu.la\/es\/botanical-solution-inc-secured-7-6-million-in-series-a-extension\/","title":{"rendered":"Botanical Solution Inc. Obtuvo $7,6 millones en una ampliaci\u00f3n de la serie A"},"content":{"rendered":"<p>Chile&#8217;s <a href=\"https:\/\/botanical-solution.com\/\" title=\"\">Botanical Solution Inc.<\/a> (BSI) has secured an additional $7.6 million as part of its Series A financing, bringing the total to $23.3 million for this round. This new investment will support the company\u2019s plans to commence in-house production of QS-21, a pharmaceutical-grade vaccine adjuvant, using its proprietary, cost-effective, and scalable methods.<\/p>\n\n\n\n<p>QS-21 is a key component in FDA-approved vaccines for Shingles and Respiratory Syncytial Virus (RSV). BSI\u2019s production method, which utilizes tissue-cultured Quillaja saponaria plants, offers a sustainable alternative to traditional extraction methods that rely on tree bark, thereby reducing environmental impact and ensuring a steady, high-quality supply of QS-21 without deforestation.<\/p>\n\n\n\n<p>The announcement was made by Gaston Salinas, CEO of BSI, during a seminar at Harvard University\u2019s Global Health, Biodiversity, and Therapeutic Hybrid Seminar in San Jose, Costa Rica. Salinas emphasized the significance of BSI&#8217;s plant tissue culture technology in addressing industry challenges and ensuring an eco-friendly supply of QS-21.<\/p>\n\n\n\n<p>The Series A funds will enable BSI to accelerate GMP (Good Manufacturing Practice) production of QS-21 for human vaccines, enhance its R&amp;D capabilities, and expand its laboratory facilities in Davis, California. The company has already established a key partnership with Croda Pharma for the production of QS-21, with plans to explore further opportunities for collaboration with vaccine developers.<\/p>\n\n\n\n<p>BSI\u2019s proprietary R&amp;D platform focuses on sustainable and consistent production of Advanced Botanical Materials (ABM). Its first product, ABM-01, derived from tissue-cultured Quillaja saponaria, is the active ingredient in BSI\u2019s biopesticide Quillibrium\u00ae and the adjuvant QS-21. <\/p>","protected":false},"excerpt":{"rendered":"<p>Botanical Solution Inc. obtiene $7,6 millones para iniciar la producci\u00f3n interna de QS-21, un adyuvante sostenible para vacunas derivado del cultivo de tejidos vegetales.<\/p>","protected":false},"author":16,"featured_media":15667,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_vp_format_video_url":"","_vp_image_focal_point":[],"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[332,410],"tags":[228,250,321],"class_list":["post-15666","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-tribu","tag-chile","tag-farm-inputs","tag-funding"],"acf":[],"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/tribu.la\/wp-content\/uploads\/2024\/08\/botanical.webp","jetpack_sharing_enabled":true,"publishpress_future_action":{"enabled":false,"date":"2026-04-20 05:16:10","action":"category","newStatus":"draft","terms":[337],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/posts\/15666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/comments?post=15666"}],"version-history":[{"count":1,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/posts\/15666\/revisions"}],"predecessor-version":[{"id":15668,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/posts\/15666\/revisions\/15668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/media\/15667"}],"wp:attachment":[{"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/media?parent=15666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/categories?post=15666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tribu.la\/es\/wp-json\/wp\/v2\/tags?post=15666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}